Found: 13
Select item for more details and to access through your institution.
Nardilysin in adipocytes regulates UCP1 expression and body temperature homeostasis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07379-x
- By:
- Publication type:
- Article
Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 5, p. 396, doi. 10.1002/emmm.201200216
- By:
- Publication type:
- Article
Nardilysin prevents amyloid plaque formation by enhancing alpha-secretase activity in vivo
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 46, n. 4, p. 1274
- By:
- Publication type:
- Article
Nardilysin controls cardiac sympathetic innervation patterning through regulation of p75 neurotrophin receptor.
- Published in:
- FASEB Journal, 2020, v. 34, n. 9, p. 11624, doi. 10.1096/fj.202000604R
- By:
- Publication type:
- Article
Critical roles of nardilysin in the maintenance of body temperature homoeostasis.
- Published in:
- Nature Communications, 2014, v. 5, n. 2, p. 3224, doi. 10.1038/ncomms4224
- By:
- Publication type:
- Article
Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system.
- Published in:
- Nature Neuroscience, 2009, v. 12, n. 12, p. 1506, doi. 10.1038/nn.2438
- By:
- Publication type:
- Article
Enhancement of α-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin.
- Published in:
- Journal of Neurochemistry, 2007, v. 102, n. 5, p. 1595, doi. 10.1111/j.1471-4159.2007.04685.x
- By:
- Publication type:
- Article
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4935, doi. 10.3390/ijms25094935
- By:
- Publication type:
- Article
Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4453, doi. 10.1111/cas.14652
- By:
- Publication type:
- Article
Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.
- Published in:
- Cancer Science, 2017, v. 108, n. 5, p. 910, doi. 10.1111/cas.13204
- By:
- Publication type:
- Article
Auxiliary roles of nardilysin in the early diagnosis of acute coronary syndrome: a prospective cohort study, the Nardi-ACS study.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 3, p. 649, doi. 10.1007/s11739-023-03508-0
- By:
- Publication type:
- Article
Nardilysin Is Required for Maintaining Pancreatic β-Cell Function.
- Published in:
- 2016
- By:
- Publication type:
- journal article